Herbert Kühl

1.6k total citations
54 papers, 1.2k citations indexed

About

Herbert Kühl is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Herbert Kühl has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Genetics and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Herbert Kühl's work include Reproductive Health and Contraception (15 papers), Hormonal and reproductive studies (15 papers) and Estrogen and related hormone effects (15 papers). Herbert Kühl is often cited by papers focused on Reproductive Health and Contraception (15 papers), Hormonal and reproductive studies (15 papers) and Estrogen and related hormone effects (15 papers). Herbert Kühl collaborates with scholars based in Germany, Austria and Switzerland. Herbert Kühl's co-authors include Inka Wiegratz, C. Jung-Hoffmann, Renate Strohmeier, Manfred Kaufmann, Olaf Herkert, Rudi Busse, Jürgen Sandow, Valérie B. Schini‐Kerth, Nicole Sänger and Katrin Mittmann and has published in prestigious journals such as Circulation, American Journal of Obstetrics and Gynecology and British Journal of Pharmacology.

In The Last Decade

Herbert Kühl

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Kühl Germany 20 454 427 348 275 174 54 1.2k
P. Fioretti Italy 27 429 0.9× 772 1.8× 638 1.8× 423 1.5× 241 1.4× 133 2.2k
I. M. Spitz Israel 19 286 0.6× 275 0.6× 504 1.4× 210 0.8× 197 1.1× 50 1.1k
H. G. Bohnet Germany 19 180 0.4× 671 1.6× 484 1.4× 269 1.0× 307 1.8× 58 1.4k
J. Neulen Germany 23 604 1.3× 223 0.5× 903 2.6× 314 1.1× 355 2.0× 75 1.8k
Sylvie Brailly France 20 462 1.0× 567 1.3× 872 2.5× 364 1.3× 376 2.2× 33 1.5k
L. M. Demers United States 22 227 0.5× 427 1.0× 334 1.0× 253 0.9× 353 2.0× 30 1.4k
B. de Lignières France 22 243 0.5× 791 1.9× 242 0.7× 763 2.8× 125 0.7× 46 1.6k
H. Mizunuma Japan 24 122 0.3× 266 0.6× 450 1.3× 265 1.0× 548 3.1× 66 1.5k
E. del Pozo Germany 24 135 0.3× 914 2.1× 312 0.9× 95 0.3× 260 1.5× 56 1.7k
Miklós Koppán Hungary 22 162 0.4× 207 0.5× 410 1.2× 120 0.4× 213 1.2× 49 1.1k

Countries citing papers authored by Herbert Kühl

Since Specialization
Citations

This map shows the geographic impact of Herbert Kühl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Kühl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Kühl more than expected).

Fields of papers citing papers by Herbert Kühl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Kühl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Kühl. The network helps show where Herbert Kühl may publish in the future.

Co-authorship network of co-authors of Herbert Kühl

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Kühl. A scholar is included among the top collaborators of Herbert Kühl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Kühl. Herbert Kühl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiegratz, Inka, Nicole Sänger, Katrin Mittmann, et al.. (2011). Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy. Contraception. 84(2). 133–143. 18 indexed citations
2.
Wiegratz, Inka, Nicole Sänger, Katrin Mittmann, et al.. (2009). Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use. Contraception. 81(1). 57–61. 20 indexed citations
5.
Wiegratz, Inka & Herbert Kühl. (2006). Metabolic and clinical effects of progestogens. The European Journal of Contraception & Reproductive Health Care. 11(3). 153–161. 48 indexed citations
6.
Wiegratz, Inka, et al.. (2006). Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest. Fertility and Sterility. 85(6). 1812–1819. 23 indexed citations
7.
Kühl, Herbert & John C. Stevenson. (2006). The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits – an attempt to interpret the Women's Health Initiative results. Gynecological Endocrinology. 22(6). 303–317. 22 indexed citations
8.
Kühl, Herbert. (2005). Breast cancer risk in the WHI study: The problem of obesity. Maturitas. 51(1). 83–97. 43 indexed citations
9.
Kühl, Herbert. (2004). Mechanisms of sex steroids. Maturitas. 47(4). 285–291. 7 indexed citations
10.
Wiegratz, Inka & Herbert Kühl. (2004). Long-Cycle Treatment with Oral Contraceptives. Drugs. 64(21). 2447–2462. 49 indexed citations
11.
Strohmeier, Renate, Marc Roller, Nicole Sänger, Rainald Knecht, & Herbert Kühl. (2002). Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells. Biochemical Pharmacology. 64(1). 99–107. 26 indexed citations
12.
Wiegratz, Inka, et al.. (2002). Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women. Maturitas. 41(2). 133–141. 11 indexed citations
13.
Strohmeier, Renate, et al.. (2000). Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines. Biochemical Pharmacology. 60(3). 397–402. 72 indexed citations
14.
Kühl, Herbert. (1998). Dienogest. Drugs. 56(5). 834–835. 3 indexed citations
15.
Kühl, Herbert. (1996). Effects of progestogens on haemostasis. Maturitas. 24(1-2). 1–19. 78 indexed citations
16.
Kühl, Herbert, C. Jung-Hoffmann, & Inka Wiegratz. (1995). Gestodene-Containing Contraceptives. Clinical Obstetrics & Gynecology. 38(4). 829–840. 15 indexed citations
17.
Himber, Jacques, et al.. (1994). Lack of effect on the low density lipoprotein receptor in hamsters treated with 17α-ethinyl estradiol. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1211(3). 359–363. 5 indexed citations
18.
Jung-Hoffmann, C. & Herbert Kühl. (1990). Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: Factors influencing steroid metabolism. American Journal of Obstetrics and Gynecology. 163(6). 2183–2197. 32 indexed citations
19.
Sandow, Jürgen, et al.. (1988). Investigations upon the mechanism of inhibition of spermatogenesis in the rat by a dimeric ethynodiol-testosterone ester. European Journal of Endocrinology. 117(4). 536–544. 2 indexed citations
20.
Kühl, Herbert, et al.. (1974). SEX STEROIDS STIMULATE THE ACTIVITY OF HYPOTHALAMIC ARYLAMIDASES IN THE RAT. European Journal of Endocrinology. 76(1). 1–14. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026